Double Blind, Two Dose, Cross-Over Clinical Trial of the Positive Allosteric Modulator at the Alpha7 Nicotinic Cholinergic Receptor AVL-3288 in Schizophrenia Patients

AVL-3288 - Anvyl

https://acnp.societyconference.com/conf/#sessions/conf10029

Joshua Kantrowitz, M.D.;Daniel Javitt;Robert Freedman;Pejman Sehatpour;Lawrence Kegeles;Tarek Sobieh;Melanie Wall;Tse Hwei Choo;Blair Vail;Jack Grinband;Jeffrey Lieberman

Oct 17, 2019